Navigation Links
Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
Date:2/14/2008

of myocardial infarction; in patients with arrhythmias, heart block conduction disturbances, or congestive heart failure; and in patients with hyperthyroidism. AMRIX may enhance the effects of alcohol, barbiturates, and other CNS depressants. AMRIX should not be used in elderly patients or in patients with impaired hepatic function. AMRIX should be used with caution in patients with a history of urinary retention, angle-closure glaucoma, increased intraocular pressure, and in patients taking anticholinergic medication.

For complete product information, visit http://www.amrix.com.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. The company's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, AMRIX, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3 4

Related biology technology :

1. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
2. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
3. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
4. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
5. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
6. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
7. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
8. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
9. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
10. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
11. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... March 11, 2010 , ProFibrix B.V., a leader in the development of ... II trial testing its unique new hemostat,Fibrocaps(TM). Promising preliminary data from the European ... good performance of the delivery device. , ... ... ...
(Date:3/10/2010)... March 10, 2010 Complete Genomics Inc., ... that the Institute for Systems Biology (ISB) employed ... a family quartet to determine the depth of ... sequence, and to verify the gene responsible for ... collaboration will be published online later today in ...
(Date:3/10/2010)... ... ... ... , ... , , ...
(Date:3/10/2010)... Photometrics releases its exclusive PVCAM universal programming interface, which supports ... Vista 64. , ... (PRWEB) March ... CCD and EMCCD cameras for the life sciences, has announced ... universal programming interface. This new driver adds support for Microsoft’s ...
Breaking Biology Technology:ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 2ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3Institute for Systems Biology uses Complete Genomics' genome sequencing service to verify gene responsible for Miller syndrome 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 3Photometrics Introduces 64-Bit PVCAM Driver 2
... Institute of Standards and Technology (NIST) have developed ... of magnetic materials such as nickel or nickel-iron ... The process, described in a recent paper,* could ... (MEMS) devices. , The NIST team also demonstrated ...
... 26 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,("Dragon Pharma" or ... a,leading international pharmaceutical company, today announced the results,of ... 2008 in Shenzhen,China., There were 48,663,865 shares ... meeting. The shareholders re-elected the following,eight persons to ...
... 26 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... has,ruled in favor of its subsidiary, Barr Laboratories, ... Boehringer Ingelheim Pharmaceuticals, Inc. in,connection with Boehringer Ingelheim,s ... 1.5mg., In his ruling, District Court Judge ...
Other Biology Technology:New process creates 3-D nanostructures with magnetic materials 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4
(Date:3/11/2010)... better manage their disease by controlling their food intake ... of needing treatment that makes them hungry, researchers said. ... prevent weight gain may suggest an eating disorder when ... Dr. Deborah Young-Hyman, pediatric psychologist at the Medical College ... use the same criteria to diagnose eating disorders that ...
(Date:3/11/2010)... PHILADELPHIA - Millions of people in both the ... immune-system research findings from the University of Pennsylvania ... researchers, studying how the immune system operates, have ... be the body,s double-edged sword, fighting off parasitic ... that can lead to allergies and asthma. , ...
(Date:3/11/2010)... Wisconsin-Madison have designed a way to harvest small amounts ... into usable hydrogen fuel. , The process is simple, ... , "This study provides a simple and cost-effective technology ... by scavenging energy wastes such as noise or stray ... new paper, published March 2 in the Journal ...
Breaking Biology News(10 mins):Diabetes' link to eating disorders explored 2Diabetes' link to eating disorders explored 3Penn researchers identify immune cells that fight parasites may promote allergies and asthma 2Scavenging energy waste to turn water into hydrogen fuel 22009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 12009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 22009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women 26apos 3Bs Health of North America in Florida 62229 3Raphaelson 26amp 3B Levine Secures 241 1 Million Verdict for Victim of New York Construction Accident 62226 1Raphaelson 26amp 3B Levine Secures 241 1 Million Verdict for Victim of New York Construction Accident 62226 2Beverage Can Stay Tabs Pose Swallowing Risk 62223 1Beverage Can Stay Tabs Pose Swallowing Risk 62223 2
... to the new study, the presence of caspase-12, which ... increases the body's "vulnerability to bacterial infection and septic ... This new discovery suggests that caspase-12 antagonists could be ... other inflammatory and immune disorders. , The study ...
... gelling agent in making jams and jellies, but its ... and may have a role in important biological functions ... , Despite the importance of pectin as a major ... known relatively little about how this family of complex ...
... among the most complex in the animal kingdom. Researchers have ... uses sound units to build phrases that can be combined ... only humans have demonstrated the ability to use such a ... March 2006 issue of the Journal of the Acoustical Society ...
Other Biology News:Lack of a key enzyme dramatically increases resistance to sepsis 2Lack of a key enzyme dramatically increases resistance to sepsis 3Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 2Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 3Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
Biology Products: